159 related articles for article (PubMed ID: 32045591)
1. Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members.
Butaney M; Thirumavalavan N; Balasubramanian A; McBride JA; Gondokusumo J; Pastuszak AW; Lipshultz LI
Urology; 2020 May; 139():104-109. PubMed ID: 32045591
[TBL] [Abstract][Full Text] [Related]
2. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members.
Yafi FA; Haney NM; Anaissie J; DeLay KJ; Trost L; Khera M; Hellstrom WJG
Urology; 2017 Aug; 106():87-95. PubMed ID: 28479477
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists.
Grossmann M; Anawalt BD; Wu FC
Clin Endocrinol (Oxf); 2015 Feb; 82(2):234-41. PubMed ID: 25154540
[TBL] [Abstract][Full Text] [Related]
4. The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy.
Punjani N; Bernie H; Salter C; Flores J; Benfante N; Mulhall JP
Sex Med; 2021 Aug; 9(4):100378. PubMed ID: 34090245
[TBL] [Abstract][Full Text] [Related]
5. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
Leder BZ; Finkelstein JS
Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
[TBL] [Abstract][Full Text] [Related]
6. Varicocele Repair Versus Testosterone Therapy for Older Hypogonadal Men with Clinical Varicocele and Low Testosterone.
Bernie HL; Goldstein M
Eur Urol Focus; 2018 Apr; 4(3):314-316. PubMed ID: 30316825
[TBL] [Abstract][Full Text] [Related]
7. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
[TBL] [Abstract][Full Text] [Related]
8. Variability in penile duplex ultrasound international practice patterns, technique, and interpretation: an anonymous survey of ISSM members.
Butaney M; Thirumavalavan N; Hockenberry MS; Kirby EW; Pastuszak AW; Lipshultz LI
Int J Impot Res; 2018 Oct; 30(5):237-242. PubMed ID: 30108336
[TBL] [Abstract][Full Text] [Related]
9. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.
Grabner M; Hepp Z; Raval A; Tian F; Khera M
J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice.
Rhoden EL; Morgentaler A
J Sex Med; 2010 Jan; 7(1 Pt 1):277-83. PubMed ID: 20104673
[TBL] [Abstract][Full Text] [Related]
11. Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
Mechlin CW; Frankel J; McCullough A
J Sex Med; 2014 Jan; 11(1):254-61. PubMed ID: 24119010
[TBL] [Abstract][Full Text] [Related]
12. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
13. Re: Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists.
Seftel AD
J Urol; 2015 Feb; 193(2):624. PubMed ID: 25617292
[No Abstract] [Full Text] [Related]
14. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
15. Testosterone and sexual function in men.
Rastrelli G; Corona G; Maggi M
Maturitas; 2018 Jun; 112():46-52. PubMed ID: 29704917
[TBL] [Abstract][Full Text] [Related]
16. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism.
Shabsigh A; Kang Y; Shabsign R; Gonzalez M; Liberson G; Fisch H; Goluboff E
J Sex Med; 2005 Sep; 2(5):716-21. PubMed ID: 16422830
[TBL] [Abstract][Full Text] [Related]
17. Testosterone therapy: Prescribing and monitoring patterns of practice in British Columbia.
Locke JA; Flannigan R; Günther OP; Skeldon S; Goldenberg SL
Can Urol Assoc J; 2021 Feb; 15(2):E110-E117. PubMed ID: 32745001
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism.
Smith RP; Khanna A; Coward RM; Rajanahally S; Kovac JR; Gonzales MA; Lipshultz LI
J Sex Med; 2013 Sep; 10(9):2326-33. PubMed ID: 23859250
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to Testosterone Therapy: A Review.
Lo EM; Rodriguez KM; Pastuszak AW; Khera M
Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.
Morgentaler A; Traish A; Hackett G; Jones TH; Ramasamy R
Sex Med Rev; 2019 Oct; 7(4):636-649. PubMed ID: 31351915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
